Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Microbiological media

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44341   clinical trials with a EudraCT protocol, of which   7370   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    9 result(s) found for: Microbiological media. Displaying page 1 of 1.
    EudraCT Number: 2018-000643-37 Sponsor Protocol Number: C-09-033 Start Date*: 2018-04-05
    Sponsor Name:Alcon Research Ltd
    Full Title: Safety and Efficacy Evaluation of Topical Moxidex Otic Solution in the Treatment of Acute Otitis Media with Otorrhea in Tympanostomy Tubes
    Medical condition: Acute Otitis Media
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021881 - Infections and infestations 10033079 Otitis media acute PT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2017-002689-30 Sponsor Protocol Number: C-13-026 Start Date*: 2017-11-20
    Sponsor Name:Alcon Research Ltd
    Full Title: Proof-of-Concept Study of a Single Application of an Investigational Otic Suspension in Treatment of Acute Otitis Media With Tympanostomy Tubes
    Medical condition: Acute otitis media
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021881 - Infections and infestations 10033079 Otitis media acute PT
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2018-000640-26 Sponsor Protocol Number: C-05-36 Start Date*: 2018-04-05
    Sponsor Name:Alcon Research Ltd
    Full Title: Safety and Efficacy Evaluation of Topical Moxidex Otic Solution Compared to Moxifloxacin Solution in the Treatment of Acute Otitis Media with Otorrhea through Tympanostomy Tubes (AOMT)
    Medical condition: acute otitis media
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021881 - Infections and infestations 10033079 Otitis media acute PT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2010-023239-40 Sponsor Protocol Number: CIFLOTIII/10IA04 Start Date*: 2011-07-27
    Sponsor Name:Laboratorios SALVAT, S.A.
    Full Title: A Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of Ciprofloxacin 0.3% plus Fluocinolone Acetonide 0.025% Otic Solution Compared to Ciprofloxacin 0.3% Otic s...
    Medical condition: Acute Otitis Media with Tympanostomy Tubes (AOMT) in Pediatric Patients
    Disease: Version SOC Term Classification Code Term Level
    14.0 10021881 - Infections and infestations 10033079 Otitis media acute PT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: ES (Completed) SE (Completed) FI (Completed) DK (Completed) CZ (Completed)
    Trial results: View results
    EudraCT Number: 2010-023238-22 Sponsor Protocol Number: CIFLOTIII/10IA02 Start Date*: 2011-07-29
    Sponsor Name:Laboratorios SALVAT, S.A.
    Full Title: A Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of Ciprofloxacin 0.3% plus Fluocinolone Acetonide 0.025% Otic Solution Compared to Ciprofloxacin 0.3% Otic s...
    Medical condition: Acute Otitis Media with Tympanostomy Tubes (AOMT) in Pediatric Patients. Otitis Media Aguda con Tubos de Timpanostomía(AOMT) en Pacientes Pediatricos
    Disease: Version SOC Term Classification Code Term Level
    13.1 10021881 - Infections and infestations 10033079 Otitis media acute PT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: ES (Completed) SE (Completed) FI (Completed) DK (Completed) CZ (Completed)
    Trial results: View results
    EudraCT Number: 2016-002927-27 Sponsor Protocol Number: OY20167 Start Date*: 2016-08-15
    Sponsor Name:University of Oulu, Department of Pediatrics, PEDEGO-Research unit
    Full Title: Effect of antimicrobial treament of acute otitis media on the intestinal micobiome in children: A randomized controlled trial
    Medical condition:
    Disease:
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: View results
    EudraCT Number: 2017-000820-83 Sponsor Protocol Number: NNL-2017 Start Date*: 2017-07-03
    Sponsor Name:University of Oulu
    Full Title: Otitis Media and Nasopharyngeal Microbiome in Children. The change of nasopharyngeal microbiome and its role as a risk factor of otitis media. Streptococcus salivarius K12 and the change of nasop...
    Medical condition: We investigate role of microbiota as the risk factor of acute otitis media in children.
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004862 10033071 Otitis LLT
    20.1 100000004862 10069718 Bacterial colonization LLT
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: View results
    EudraCT Number: 2017-003164-13 Sponsor Protocol Number: T17-081 Start Date*: 2018-05-17
    Sponsor Name:Haga Teaching Hospital (Juliana Children's Hospital)
    Full Title: Antibiotic prophylaxis for children with recurrent respiratory infections: towards evidence-based guidelines
    Medical condition: Recurrent respiratory tract infections in children
    Disease: Version SOC Term Classification Code Term Level
    25.1 100000004862 10038133 Recurrent respiratory tract infections LLT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-003446-45 Sponsor Protocol Number: TBTCS31/A5349 Start Date*: 2016-02-25
    Sponsor Name:Unidad de investigación en Tuberculosis de Barcelona
    Full Title: Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: A randomized, open-label, controlled phase 3 clinical trial
    Medical condition: Pulmonary tuberculosis
    Disease:
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat Jun 07 10:47:49 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA